|
US2021040566A1
|
|
Method for predicting response of patients with malignant diseases to immunotherapy
|
|
DE102017125780B3
|
|
Method for determining the response of a malignant disease to immunotherapy
|
|
DE102016005947B3
|
|
A method for estimating the prognosis and predicting the response to immunotherapy of patients with malignant diseases
|
|
DE102015009187B3
|
|
Method for determining a mutation in genomic DNA, use of the method and kit for carrying out the method
|
|
US2010021902A1
|
|
Method for methylation-selective amplification
|
|
WO2008009365A2
|
|
A method for determining the methylation rate of a nucleic acid
|
|
WO2007085497A2
|
|
Markers for the prediction of outcome of anthracycline treatment
|
|
WO2007003397A2
|
|
Method and nucleic acids for the improved treatment of cancers
|
|
WO2006133866A2
|
|
Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
|
|
US2009075251A1
|
|
Method for analysis of cytosine methylation
|
